Lee Danner & Bass Inc Amgen Inc Transaction History

Lee Danner & Bass Inc

$1.42 Billion
Q3 2024

A detailed history of Lee Danner & Bass Inc transactions in Amgen Inc stock. As of the latest transaction made, Lee Danner & Bass Inc holds 23,448 shares of AMGN stock, worth $6.57 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

23,448

Previous 23,353 0.41%

Holding current value

$6.57 Million

Previous $7.3 Million 3.54%

% of portfolio

0.53%

Previous 0.56%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$309.38 - $337.38 $29,391 - $32,051	95 Added 0.41%	23,448 $7.56 Million
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $7,882 - $9,579	30 Added 0.13%	23,353 $7.3 Million
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $910,803 - $1.03 Million	-3,562 Reduced 13.25%	23,323 $6.72 Million
Q3 2023 Oct 27, 2023	SELL	$218.65 - $271.46 $322,508 - $400,403	-1,475 Reduced 5.2%	26,885 $7.23 Million
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $121,475 - $148,057	-538 Reduced 1.86%	28,360 $6.86 Million
Q4 2022 Feb 01, 2023	SELL	$229.03 - $291.01 $707,702 - $899,220	-3,090 Reduced 9.66%	28,898 $7.59 Million
Q3 2022 Oct 31, 2022	SELL	$224.46 - $253.15 $246,232 - $277,705	-1,097 Reduced 3.32%	31,988 $7.21 Million
Q2 2022 Jul 25, 2022	SELL	$230.71 - $256.74 $182,030 - $202,567	-789 Reduced 2.33%	33,085 $8.05 Million
Q1 2022 Apr 27, 2022	SELL	$219.27 - $242.57 $63,369 - $70,102	-289 Reduced 0.85%	33,874 $8.19 Million
Q4 2021 Jan 27, 2022	SELL	$198.88 - $227.6 $176,406 - $201,881	-887 Reduced 2.53%	34,163 $7.69 Million
Q3 2021 Nov 01, 2021	SELL	$212.27 - $248.7 $102,526 - $120,122	-483 Reduced 1.36%	35,050 $7.45 Million
Q2 2021 Jul 27, 2021	SELL	$233.58 - $259.14 $50,453 - $55,974	-216 Reduced 0.6%	35,533 $8.66 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $66,645 - $79,362	308 Added 0.87%	35,749 $8.22 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $66,875 - $74,370	285 Added 0.81%	35,441 $9.01 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $147,170 - $180,598	-744 Reduced 2.07%	35,156 $8.29 Million
Q1 2020 May 04, 2020	BUY	$182.24 - $241.7 $296,140 - $392,762	1,625 Added 4.74%	35,900 $7.28 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $331,685 - $426,329	-1,753 Reduced 4.87%	34,275 $8.26 Million
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $21,763 - $26,077	-125 Reduced 0.35%	36,028 $6.97 Million
Q2 2019 Jul 30, 2019	SELL	$166.7 - $195.41 $24,171 - $28,334	-145 Reduced 0.4%	36,153 $6.66 Million
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $92,786 - $104,590	513 Added 1.43%	36,298 $6.9 Million
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $60,656 - $70,805	340 Added 0.96%	35,785 $6.97 Million
Q3 2018 Nov 06, 2018	SELL	$185.29 - $208.89 $56,698 - $63,920	-306 Reduced 0.86%	35,445 $7.35 Million
Q2 2018 Aug 06, 2018	SELL	$166.05 - $186.51 $236,621 - $265,776	-1,425 Reduced 3.83%	35,751 $7.03 Million
Q1 2018 May 02, 2018	BUY	$169.43 - $198.0 $618,758 - $723,096	3,652 Added 10.89%	37,176 $6.34 Million
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $48,949 - $54,691	290 Added 0.87%	33,524 $5.83 Million
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $5.56 Million - $6.35 Million	33,234	33,234 $6.2 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Danner & Bass Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lee Danner & Bass Inc with notifications on news.

Account

Lee Danner & Bass Inc Amgen Inc Transaction History